BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...
A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...
Doctors explain the difference between normal age-related memory lapses and concerning symptoms of dementia, with tips on ...
Dementia affects nearly a million people in the UK, but spotting it early can help slow down the onset of symptoms as one ...
But the 72-year-old Mendoza, who has not been diagnosed with Alzheimer’s, isn’t getting the exam at a doctor’s office or a clinical lab. She’s in a comfortable and familiar place, sipping Cuban coffee ...
Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite ...
Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...
Denis Law's passing has sparked calls for the Hampden Main Stand to be renamed, but his legacy could also be honoured by helping football's ...
This woolly layer is more than a social media trend – it’s an essential tool to regulate body temperature and protect your ...
Hosted on MSN5d
Dementia and stroke symptom 'can be seen in the eye' as urgent warning to get test issuedA new diagnostic tool is being developed to diagnose the most common form of dementia, Alzheimer's Disease, through a simple ...
When someone with dementia loses their ability to have empathy, caring for them can become isolating and fraught, research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback